PCDH18 is frequently inactivated by promoter methylation in colorectal cancer
Abstract Protocadherin18 (PCDH18) was found to be preferentially methylated and inactivated in colorectal cancer (CRC) using bioinformatics tools. However, its biologic role in tumorgenesis remains unclear. Herein, we aimed to elucidate its epigenetic regulation and biological functions in CRC. The...
Guardado en:
Autores principales: | Dan Zhou, Weiwei Tang, Guoqiang Su, Mingquan Cai, Han-Xiang An, Yun Zhang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/86ea3e61d1f44fe1b263cc2f241253d6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Hsa_circ_0001666 suppresses the progression of colorectal cancer through the miR‐576‐5p/PCDH10 axis
por: Jiahui Zhou, et al.
Publicado: (2021) -
Frequent and simultaneous epigenetic inactivation of TP53 pathway genes in acute lymphoblastic leukemia.
por: Amaia Vilas-Zornoza, et al.
Publicado: (2011) -
Aberrant gene promoter methylation associated with sporadic multiple colorectal cancer.
por: Victoria Gonzalo, et al.
Publicado: (2010) -
Proposed therapy, developed in a Pcdh15-deficient mouse, for progressive loss of vision in human Usher syndrome
por: Saumil Sethna, et al.
Publicado: (2021) -
PRMT3 promotes tumorigenesis by methylating and stabilizing HIF1α in colorectal cancer
por: Xin Zhang, et al.
Publicado: (2021)